Low-Dose Aspirin Associated With Reduced CRC Risk Low-Dose Aspirin Associated With Reduced CRC Risk

A Norwegian nationwide study revealed that the impact of low-dose aspirin use was greatest for metastatic colorectal cancer and increased with a longer duration of use.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Gastroenterology Source Type: news